1-2 of 2
Amy Harlow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Activating KRAS Mutation in Imatinib Resistant Chronic Myeloid Leukemia.

Anupriya Agarwal, PhD, Christopher A. Eide, BA, Amy Harlow, Jeffrey W. Tyner, PhD, Michael J. Mauro, MD, Christopher L. Corless, MD, PhD, Michael C. Heinrich, MD, Brian J. Druker, MD, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1006.
https://doi.org/10.1182/blood.V110.11.1006.1006
Published: 2007
Journal Articles

In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets

Bianca F. Goemans, Christian M. Zwaan, Amy Harlow, Anne H. Loonen, Brenda E. S. Gibson, Karel Hählen, Dirk Reinhardt, Ursula Creutzig, Michael C. Heinrich, Gertjan J. L. Kaspers
Journal: Blood
Blood (2005) 106 (10): 3532–3537.
https://doi.org/10.1182/blood-2005-04-1640
Published: 2005